Alpha Arbutin vs Kojic Acid

Alpha Arbutin: Targets melanin production; clinical data mainly involve combination creams. Kojic Acid: May help uneven pigmentation, often as part of a combination treatment.

Research updated 2026-10-25
Four alpha arbutin products lined up on white: three dropper serums and a pink cream tubeFive kojic acid products on white, including a turmeric serum, Medicube capsule cream, Admire My Skin and Seoul Ceuticals

Which one is right for you?

Choose Alpha Arbutin if…

Consider for uneven tone; do not assume it matches prescription pigment treatments.

  • Mild uneven tone or dark marks
  • You want a gentler pigment option
  • You use daily sunscreen

Choose Kojic Acid if…

Consider for uneven pigment if tolerated; evidence is mainly for combinations.

  • Mild uneven tone
  • Hydroquinone isn’t an option
  • You tolerate actives
Often combined

Can you use both?

Often found together in brightening serums. Kojic acid can irritate some skin.

At a glance

● Alpha Arbutin
● Kojic Acid
Type
Pigment-targeting ingredient
Pigment-targeting ingredient
What it does
Targets melanin production; clinical data mainly involve combination creams.
May help uneven pigmentation, often as part of a combination treatment.
Best for
Melasma
Melasma
Studied concentrations
A trial used 5% alpha-arbutin plus 2% kojic acid; this is not a recommended home strength.
2% added to hydroquinone and glycolic acid in the cited melasma study.
When to use
On the schedule specified for the product or prescribed treatment.
On the schedule specified for the product or prescribed treatment.
Time to results
Usually assessed over 8–16 weeks
Usually assessed over 8–16 weeks
Irritation
May cause irritation or a rash; choose a compliant commercial formula.
Can cause stinging, redness or contact dermatitis.
Sensitive skin
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.
Available
Prescription or cosmetic status depends on the active, formula and country; check the label.
Prescription or cosmetic status depends on the active, formula and country; check the label.

What it helps

Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.

Evidence level
Alpha Arbutin
Kojic Acid
Limited evidenceEarly or small studies
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

A small trial supports a combined alpha-arbutin and kojic acid cream.
Flat tan patches with soft irregular edges across the forehead and upper cheek of an adult with light skin, the surface completely smooth.

Melasma

Adding 2% kojic acid improved results in a small combination-treatment trial.
Insufficient evidence
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

Independent benefit for post-acne marks is not established by these studies.
AI-generated educational illustration of Sun Spots: 1. Sun Spots Header — Light Skin; Lighter skin. Not a clinical photograph.

Sun Spots

The cited melasma and laboratory studies do not establish sun-spot clearance.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
Inflamed acne on light skin. The spots sit in a patch of pink, and the ring of redness around each one is easy to see. A few have a yellow-white head, and the skin between them is dry and flaking.

Acne

The reviewed sources do not establish this ingredient as a treatment for this concern.
Flat light-brown residual marks on a fair cheek.

Post-Inflammatory Hyperpigmentation

The cited melasma trial does not establish an independent effect on post-acne marks.
AI-generated educational illustration of Sun Spots: 1. Sun Spots Header — Light Skin; Lighter skin. Not a clinical photograph.

Sun Spots

The reviewed sources do not establish this ingredient as a treatment for this concern.
The front of a forearm on fair skin. Two pale patches with sharp edges sit against lightly tanned skin, and the difference between the patch and the skin around it is subtle.

Vitiligo

The reviewed sources do not establish this ingredient as a treatment for this concern.
Sensitive Skin on light skin.

Sensitive Skin

The reviewed sources do not establish this ingredient as a treatment for this concern.
How it works

Alpha Arbutin

Alpha Arbutin mechanism diagram. Acts on pigment pathways: Laboratory models show reduced tyrosinase activity. Less melanin is made: Topical results depend on the finished formula.
Open full-size diagram
Diagram explanation and sources

Acts on pigment pathways: Laboratory models show reduced tyrosinase activity. Less melanin is made: Topical results depend on the finished formula.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1 · Source 2

Kojic Acid

Kojic Acid mechanism diagram. Reduces tyrosinase activity: Kojic acid interferes with melanin production. Less new pigment forms: Effects depend on the formula and tolerance.
Open full-size diagram
Diagram explanation and sources

Reduces tyrosinase activity: Kojic acid interferes with melanin production. Less new pigment forms: Effects depend on the formula and tolerance.

Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation.

Source 1

Using both in one routine

Built from where each one usually sits in a routine. Introduce one at a time.

Morning
Step 1
Cleanser
Step 2
Alpha ArbutinMorning or night
Step 3
Moisturizer
Step 4
Sunscreen
Night
Step 1
Cleanser
Step 2
Alpha ArbutinMorning or night
Step 3
Kojic AcidNight
Step 4
Moisturizer

Strengths and forms

Concentrations

Alpha-arbutin percentages need a regional and product-type context. EU cosmetic limits are 2% in face creams and 0.5% in body lotions; these are safety limits, not proven optimal treatment doses.

0.5%

2%

EU body-lotion ceiling

A maximum for the specified EU product category, not a minimum effective concentration.

EU face-cream ceiling

A maximum for the specified EU product category. It does not establish that 2% will work better than every lower-strength formula.

Choosing a strength: Check that the ingredient is alpha-arbutin. Beta-arbutin has different specifications and should not share the same strength scale.

Higher strengths: A higher concentration in a clinical combination study does not override current cosmetic restrictions or establish safe home use.

Formula matters: The extract or ingredient identity, purity and the finished formula matter. Hydroquinone impurities must be controlled.

Kojic acid concentrations in older studies differ from current cosmetic limits. In the EU, kojic acid is limited to 1% in face and hand products; that is not a universal treatment target.

1%

2%

EU cosmetic ceiling

The maximum in specified face and hand products. This is a regulatory limit, not proof of the best efficacy.

Older combination-study strength

Studied with hydroquinone and glycolic acid. The combination result does not isolate kojic acid or establish a current home-use recommendation.

Choosing a strength: Check local rules and the full formula. Kojic acid and kojic dipalmitate are different ingredients and cannot be compared by percentage alone.

Higher strengths: Do not use an older trial’s concentration as a reason to exceed current limits. Irritation or allergic contact dermatitis can occur.

Formula matters: Combination products may obtain benefit from several ingredients. A study of a combination cannot tell you what kojic acid alone contributed.

Forms
Serum · Cream
Serum · Soap · Cream

When you’ll see results

Approximate windows, not promises.

● Alpha Arbutin
● Kojic Acid
First few weeks

First few weeksAssess tolerance first; pigment change is usually slower.

First few weeksAssess tolerance first; pigment change is usually slower.

4–8 weeks

4–8 weeksSome studied regimens begin showing pigment improvement.

4–8 weeksSome studied regimens begin showing pigment improvement.

8–12 weeks

8–12 weeksA useful review point for benefit and irritation.

8–12 weeksA useful review point for benefit and irritation.

3–6 months

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

3–6 monthsMany melasma trials assess results over three to four months; recurrence is common.

6–12 months

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

6–12 monthsLong-term use depends on the active; follow a monitored plan rather than extending treatment automatically.

Safety and sensitive skin

Common reactions

May cause irritation or a rash; choose a compliant commercial formula.

Can cause stinging, redness or contact dermatitis.

When to stop

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.

Sensitive or inflamed skin

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Choose a simple formula and test a small area first. Avoid actively inflamed or broken skin unless the product is specifically directed for it.

Important limits

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.

Pregnancy

Because it releases small amounts of hydroquinone, ask rather than assume; pregnancy-specific data are limited. Ask the doctor managing your pregnancy. Azelaic acid and strict sun protection are the usual suggestions meanwhile.

There is not much pregnancy-specific data on kojic acid, and melasma often appears or worsens in pregnancy. Ask the doctor managing your pregnancy first. Azelaic acid and strict sun protection are the usual alternatives.

How it works

In the skin

On the skin. The finished product delivers alpha arbutin in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Laboratory models show reduced tyrosinase activity and melanin production; clinical delivery and formula matter.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

On the skin. The finished product delivers kojic acid in a particular vehicle.

Entering skin. Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.

Conversion. No activation step is established as necessary for its intended topical role.

Skin response. Inhibits tyrosinase activity involved in melanin production; cosmetic formulas differ from studied combinations.

Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.

Getting in
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Below the 500 Da guideline; delivery still depends on the formula, solubility, stability and skin condition. Size does not prove effectiveness or penetration depth.
Molecule size
Alpha Arbutin · 272 Da
Kojic Acid · 142 Da
Smaller than 500 Da passes the outer skin more easily. Size isn’t an effectiveness score.
500 Da guideline

Product examples

Alpha Arbutin
  • The Ordinary Alpha Arbutin 2% + HA
  • Naturium Alpha Arbutin Serum 2%
  • COSRX The Alpha-Arbutin 2 Discoloration Care Serum
Kojic Acid
  • Naturium Tranexamic Topical Acid — 5% tranexamic acid with kojic acid and niacinamide, for $20. Well built, and no serum fixes melasma alone.
  • MediCube Kojic Acid Turmeric Body Peel Shot
  • MediCube Kojic Acid Turmeric Peel Shot

Common questions

Alpha Arbutin:What should I choose alpha arbutin for?

Consider for uneven tone; do not assume it matches prescription pigment treatments.

Alpha Arbutin:How strong is the evidence?

A 30-person split-face trial tested alpha-arbutin together with kojic acid. Laboratory results cannot establish clinical efficacy alone, and nonsignificant differences do not prove equivalence.

Kojic Acid:What should I choose kojic acid for?

Consider for uneven pigment if tolerated; evidence is mainly for combinations.

Kojic Acid:How strong is the evidence?

A 40-woman split-face trial added kojic acid to hydroquinone and glycolic acid. It does not show that kojic acid alone performs as well as the combination or that higher strengths are better.

Sources

Sources and further reading

  1. The Efficacy of Topical Cosmetic Containing Alpha-Arbutin 5% and Kojic Acid 2% Compared With Triple Combination Cream for the Treatment of Melasma: A Split-Face, Evaluator-Blinded Randomized Pilot Study. (2025)
  2. Inhibitory effects of alpha-arbutin on melanin synthesis in cultured human melanoma cells and a three-dimensional human skin model. (2004)
  3. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. (1999)
  4. EU Regulation 2024/996: cosmetic concentration restrictions
  5. SCCS opinion on alpha- and beta-arbutin
Dermapedia on YouTube